CV-3988 CV-3988 is a specific antagonist of PAF binding to the PAF-R. It inhibits PAF-induced platelet aggregation.

CV-3988  (CAS 85703-73-7)

CV-3988 is rated 5.0 out of 5 by 1.
  • 2016-09-28T11:20CST
  • bvseo_cps, prod_bvrr, vn_cps_3.4.0
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_201015, PRD, sort_relevancy
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 97ms
  • REVIEWS, PRODUCT
Synonym: rac-3-(N-Octadecylcarbamoyl)-2-Methoxy) propyl-(2- thiazolioethyl) phosphate
Application: A specific antagonist of PAF binding to PAF-R
CAS Number: 85703-73-7
Purity: 98%
Molecular Weight: 592.77
Molecular Formula: C28H53N2O7PS
* Refer to Certificate of Analysis for lot specific data (including water content).
submit a review for this product and receive 15 cruzcredits

Ordering Information

PRODUCT NAME CATALOG # UNIT PRICE QTY FAVORITES
CV-3988 sc-201015 5 mg $147.00
CV-3988 sc-201015A 25 mg $599.00

CV-3988 is a specific antagonist of PAF-R (platelet-activating factor receptor), blocking signaling events correlated to the expression and binding of PAF to the PAF-R (Ki = 0.872 μM). CV-3988 has close structural similarity to PAF allowing recognition by the receptor, where it then associates strongly to the binding site and blocks the activating interaction with PAF. Inhibition of this binding has been used to investigate the numerous cellular consequences of PAF association to the PAF-R. PAF-induced platelet aggregation is inhibited by CV-3988. Mediation of the severity of endotoxin shock was demonstrated upon administration of CV-3988, indicating that PAF serves a pivotal role in the pathogenesis of endotoxin shock. The lethality of anaphylactic shock in mice was also subdued in the presence of CV-3988, suggesting a lethal role of PAF in the anaphylaxis. As a specific antagonist of PAF binding, CV-3988 has seen wide utility as a benchmark PAF-binding antagonist for binding studies with other compounds.


References

1. Terashita, Z., et al. 1983. Life Sci. 32: 1975-1982. PMID: 6403793
2. Terashita, Z., et al. 1985. Biochem. Pharmacol. 34: 1491-1495. PMID: 2986648
3. Terashita, Z., et al. 1985. Eur. J. Pharmacol. 109: 257-261. PMID: 3996473
4. Hwang, S.B. and Lam, M.H. 1986. Biochem. Pharmacol. 35: 4511-4518. PMID: 3024653
5. Terashita, Z., et al. 1987. J. Pharmacol. Exp. Ther. 243: 378-383. PMID: 3118009
6. Hayashi, M., et al. 1987. Jpn. J. Pharmacol. 44: 127-134. PMID: 2888915
7. Robertson, D.A., et al. 1988. J. Pharmacol. Exp. Ther. 245: 124-128. PMID: 3361438

Appearance :
Powder
Physical State :
Solid
Solubility :
Soluble in ethanol (15 mg/ml), and DMSO (≥10 mg/ml).
Storage :
Store at -20° C
IC50 :
Platelet activating factor receptor: IC50 = 600 nM (human); Oryctolagus cuniculus: EC5050 = 30.5 µM
pK Values :
pKa: 1.27
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
WGK Germany :
3
PubChem CID :
107681
MDL Number :
MFCD00133274
SMILES :
CCCCCCCCCCCCCCCCCCNC(=O)OCC(COP(=O)([O-])OCC[N+]1=CSC=C1)OC

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

You May Also Like

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 54ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Lee CM; et al Lee CM; et al. (PubMed ID: 24754407) determined that CV3988 could decrease opacity and neovascularization in alkali burn-induced corneas in mice. -SCBT Publication Review
Date published: 2015-03-11
  • 2016-09-28T11:20CST
  • bvseo_cps, prod_bvrr, vn_cps_3.4.0
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_201015, PRD, sort_relevancy
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 7ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2016 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.